APA (7th ed.) Citation

Naghavi, A. O., Bryant, J. M., Kim, Y., Weygand, J., Redler, G., Sim, A. J., . . . Eschrich, S. A. (2024). Habitat escalated adaptive therapy (HEAT): A phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma. BMC Cancer, 24(1), 1. https://doi.org/10.1186/s12885-024-12151-7

Chicago Style (17th ed.) Citation

Naghavi, Arash O., et al. "Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-directed and Genomic-adjusted Radiation Dose (GARD) Optimization for High-grade Soft Tissue Sarcoma." BMC Cancer 24, no. 1 (2024): 1. https://doi.org/10.1186/s12885-024-12151-7.

MLA (9th ed.) Citation

Naghavi, Arash O., et al. "Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-directed and Genomic-adjusted Radiation Dose (GARD) Optimization for High-grade Soft Tissue Sarcoma." BMC Cancer, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12885-024-12151-7.